{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T03:26:34Z","timestamp":1793589994863,"version":"4.5.0"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ejim.2026.107077","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T04:04:07Z","timestamp":1784088247000},"page":"107077","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Targeting the kidney-gut axis in chronic kidney disease: From biological insight to therapeutic opportunity"],"prefix":"10.1016","volume":"153","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7137-0354","authenticated-orcid":false,"given":"Domenico","family":"Bagordo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Santacroce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1131-8666","authenticated-orcid":false,"given":"Giorgia","family":"Adiutori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Biasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Vittoria","family":"Parola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0302-8645","authenticated-orcid":false,"given":"Antonio","family":"Di Sabatino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2026.107077_bib0001","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/S0140-6736(25)01853-7","article-title":"Chronic Kidney Disease Collaborators. Global, regional, and national burden of chronic kidney disease in adults, 1990-2023, and its attributable risk factors: a systematic analysis for the Global Burden of Disease Study 2023","volume":"406","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2026.107077_bib0002","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1093\/ndt\/gfv095","article-title":"Altered intestinal microbial flora and impaired epithelial barrier structure and function in CKD: the nature, mechanisms, consequences and potential treatment","volume":"31","author":"Vaziri","year":"2016","journal-title":"Nephrol Dial Transplant: Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc"},{"key":"10.1016\/j.ejim.2026.107077_bib0003","doi-asserted-by":"crossref","first-page":"451","DOI":"10.2215\/CJN.0000000588","article-title":"Residual risk of adverse kidney and cardiovascular outcomes in patients with CKD","volume":"20","author":"Khan","year":"2025","journal-title":"Clin j Am Soc Nephrol: CJASN"},{"key":"10.1016\/j.ejim.2026.107077_bib0004","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242216152","article-title":"The AKI-to-CKD transition: the role of Uremic toxins","volume":"24","author":"Andr\u00e9","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ejim.2026.107077_bib0005","doi-asserted-by":"crossref","first-page":"6196","DOI":"10.3390\/ijms22126196","article-title":"Uremic toxins and their relation with oxidative stress induced in patients with CKD","volume":"22","author":"Pieniazek","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ejim.2026.107077_bib0006","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1161\/ATVBAHA.120.314139","article-title":"Targeted inhibition of gut microbial trimethylamine N-oxide production reduces renal tubulointerstitial fibrosis and functional impairment in a murine model of chronic kidney disease","volume":"40","author":"Gupta","year":"2020","journal-title":"Arter Thromb Vasc Biol"},{"key":"10.1016\/j.ejim.2026.107077_bib0007","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000360010","article-title":"Expansion of urease- and uricase-containing, indole- and p-cresol-forming and contraction of short-chain fatty acid-producing intestinal microbiota in ESRD","volume":"39","author":"Wong","year":"2014","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.ejim.2026.107077_bib0008","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-023-04455-2","article-title":"The gut microbiome tango in the progression of chronic kidney disease and potential therapeutic strategies","author":"Tang","year":"2023","journal-title":"J Transl Med Internet"},{"key":"10.1016\/j.ejim.2026.107077_bib0009","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1161\/HYPERTENSIONAHA.123.19569","article-title":"Tangram of sodium and fluid balance","volume":"81","author":"Bagordo","year":"2024","journal-title":"Hypertension"},{"key":"10.1016\/j.ejim.2026.107077_bib0010","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3390\/toxins10090367","article-title":"Impacts of indoxyl sulfate and p-cresol sulfate on chronic kidney disease and mitigating effects of AST-120","volume":"10","author":"Liu","year":"2018","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.ejim.2026.107077_bib0011","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/s41581-022-00654-0","article-title":"The gut microbiome and hypertension","volume":"19","author":"O\u2019Donnell","year":"2023","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.ejim.2026.107077_bib0012","doi-asserted-by":"crossref","DOI":"10.1080\/0886022X.2023.2300314","article-title":"Canagliflozin attenuates kidney injury, gut-derived toxins, and gut microbiota imbalance in high-salt diet-fed Dahl salt-sensitive rats","volume":"46","author":"He","year":"2024","journal-title":"Ren Fail"},{"key":"10.1016\/j.ejim.2026.107077_bib0013","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s40200-025-01834-y","article-title":"Bidirectional interplay between the gut microbiota and GLP-1 receptor agonists: towards microbiome-mediated therapeutics in type 2 diabetes mellitus","volume":"25","author":"Ganamurali","year":"2026","journal-title":"J Diabetes Metab Disord"},{"key":"10.1016\/j.ejim.2026.107077_bib0014","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1053\/j.jrn.2022.07.008","article-title":"The impact of synbiotic treatment on the levels of gut-derived uremic toxins, inflammation, and gut microbiome of chronic kidney disease patients-A randomized trial","volume":"33","author":"Mitrovi\u0107","year":"2023","journal-title":"J Ren Nutr: Off J Counc Ren Nutr Natl Kidney Found"},{"key":"10.1016\/j.ejim.2026.107077_bib0015","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0140-6736(08)60207-X","article-title":"Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial","volume":"371","author":"Besselink","year":"2008","journal-title":"Lancet"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620526003821?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620526003821?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T02:54:14Z","timestamp":1793588054000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620526003821"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":15,"alternative-id":["S0953620526003821"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2026.107077","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting the kidney-gut axis in chronic kidney disease: From biological insight to therapeutic opportunity","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2026.107077","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Federation of Internal Medicine. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107077"}}